Skip to main content
logo
Cytogen, Inc. (KOSDAQ:217330)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,055.00
-35.00 (-1.13%)
At close: Sep 11, 2026

Cytogen Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-10,548-12,343-17,117-15,770-18,771-10,871
Depreciation & Amortization
2,7763,1752,0881,9121,3141,114
Loss (Gain) From Sale of Assets
67.1153.17079.3300
Asset Writedown & Restructuring Costs
3,0883,0843,4863,164--
Loss (Gain) From Sale of Investments
931.47931.472,8961,412-139.47-472.78
Stock-Based Compensation
395.85194.51568.381,8662,8065,453
Provision & Write-off of Bad Debts
133.94105.33179.58153.492.88-
Other Operating Activities
1,4772,4461,29996.498,785-493.66
Change in Accounts Receivable
-1,461-2,352-2,444-11.91-235.79473.7
Change in Inventory
-1,354-3,220-1,48833.25-131.47-
Change in Accounts Payable
-440.271,7981,56617.1435.3745.54
Change in Other Net Operating Assets
-674.31-827.06-564.08-545.32-43.44-479.02
Operating Cash Flow
-5,608-6,954-9,529-7,594-6,379-5,230
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,752-1,970-1,007-2,498-645.8-1,219
Sale of Property, Plant & Equipment
0.8891.451.3278.94-0.76
Cash Acquisitions
-15.99--13,184--9,561-
Sale (Purchase) of Intangibles
-70.3-67.43-117.27175.58-99.24-777.85
Investment in Securities
9,500-10,000-9,8572,3853,592-4,030
Other Investing Activities
143.5382.54-185.71121.5260.59140.93
Investing Cash Flow
7,806-11,864-24,349263.39-6,654-5,585

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---3,083--
Long-Term Debt Issued
--9,80017,934-30,000
Total Debt Issued
5,200-9,80021,017-30,000
Short-Term Debt Repaid
---905.16-2,571--
Long-Term Debt Repaid
--1,361-6,251-11,840-493.12-426.55
Total Debt Repaid
-10,623-1,361-7,156-14,411-493.12-426.55
Net Debt Issued (Repaid)
-5,423-1,3612,6446,606-493.1229,573
Issuance of Common Stock
--6,50040,0001,119409.95
Other Financing Activities
1.621.6228.05-369.5-1,66543.29
Financing Cash Flow
-5,422-1,3609,17246,236-1,03930,027

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
16.26-32.39-17.3353.61-338.4-
Miscellaneous Cash Flow Adjustments
0-----0
Net Cash Flow
-3,207-20,210-24,72438,960-14,41019,212

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7,360-8,924-10,536-10,092-7,024-6,449
Free Cash Flow Growth
------
Free Cash Flow Margin
-26.88%-34.25%-96.56%-316.91%-923.33%-1853.87%
Free Cash Flow Per Share
-318.64-386.85-466.34-551.82-397.69-380.57
Levered Free Cash Flow
-10,803-3,828-11,340-13,7344,146-
Unlevered Free Cash Flow
-9,415-2,369-10,033-11,8366,599-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
11.55-33.7116.8--
Cash Income Tax Paid
--71.09187.12-44.5721.79-23.61
Change in Working Capital
-3,929-4,600-2,929-506.84-375.3340.22